One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Asia-Pacific Veterinary Vaccine Market

[ 英語タイトル ] Asia-Pacific Veterinary Vaccine Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083622
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Study Area : Asia Pacific
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3750 / Question Form
5 User USD4250 / Question Form
Enterprise User USD7000 / Question Form
 - Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco
- Hester Biosciences Ltd
- Merck & Co.
- Phibro Animal Health Corp.
- Virbac SA
- Zoetis Inc.

[Report Description]

The Asia-Pacific veterinary vaccine market is expected to witness a CAGR of 6.12% over the forecast period. The key factors propelling the growth of this market are the increasing incidences of livestock diseases, initiatives by various government agencies, animal associations, leading players in the Asia-Pacific region, and the increasing incidences of zoonotic diseases.

According to the National Dairy Development Board 2017, India has a cattle population of 158.7 million and it has one of the largest animal husbandry sectors in the world, along with the largest livestock population, with 520.6 million heads. Furthermore, in 2016, Zoetis and Merial entered into an agreement for marketing and distribution drugs and vaccines for dairy cattle in India. Merial is expected to market and sell Zoetis products, including brands, such as Bovical, Rispoval, Spirovac, and many others. Thus, increasing cattle population in the region and increasing prevalence of diseases, along with improved distribution reach, with vaccine institutes reaching smaller districts, are some of the factors that are augmenting the growth of the market.

Key Market Trends

The Live Attenuated Vaccines Segment is Expected to Hold the Largest Market Share

The live attenuated vaccines segment of the Asia-Pacific veterinary vaccine market is believed to have the largest market size. Most of the vaccines licensed for oral or intranasal administration are attenuated. These vaccines must be stored and handled properly, with strict attention to temperature, even in the lyophilized (free-dried) state. After the reconstitution, the vaccine dose should be administered promptly (within 1 hour) or discarded. Some examples of these types of vaccines include canine distemper virus vaccines and all canine parvovirus and adenovirus-2 vaccines. Hence, it is expected to impact positively on the market in this segment.

Competitive Landscape

The Asia-Pacific veterinary vaccine market is a moderately consolidated market and consists of several major players. In terms of market share, a few of the major players currently dominate the market. Companies, like Zoetis Inc., Merck & Co. Inc., Virbac, Eli Lily and Company, and Boehringer Ingelheim International GmbH, hold the substantial market share in the Asia-Pacific veterinary vaccine market.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Diseases in Animals
4.2.2 Initiatives by Various Government Agencies, Animal Associations, and Leading Players
4.3 Market Restraints
4.3.1 High Storage Costs for Vaccines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Animal Vaccine Type
5.1.1 Livestock Vaccines Bovine Vaccines Poultry Vaccines Porcine Vaccines Other Livestock Vaccines
5.1.2 Companion Animal Vaccines Canine Vaccines Feline Vaccines Equine Vaccines
5.2 By Technology
5.2.1 Live Attenuated Vaccines
5.2.2 Inactivated Vaccines
5.2.3 Toxoid Vaccines
5.2.4 Recombinant Vaccines
5.2.5 Other Technologies
5.3 Geography
5.3.1 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

6.1 Company Profiles
6.1.1 Boehringer Ingelheim International GmbH
6.1.2 Ceva Sante Animale
6.1.3 Elanco
6.1.4 Hester Biosciences Ltd
6.1.5 HIPRA
6.1.6 Merck & Co.
6.1.7 Phibro Animal Health Corp.
6.1.8 Virbac SA
6.1.9 Zoetis Inc.




Recommended reports